ES2422739T3 - Composición para el diagnóstico, prevención o tratamiento de enfermedades relacionadas con células que expresan IL-8 o GRO-, que comprende MSC de UCB - Google Patents
Composición para el diagnóstico, prevención o tratamiento de enfermedades relacionadas con células que expresan IL-8 o GRO-, que comprende MSC de UCBInfo
- Publication number
- ES2422739T3 ES2422739T3 ES08793529T ES08793529T ES2422739T3 ES 2422739 T3 ES2422739 T3 ES 2422739T3 ES 08793529 T ES08793529 T ES 08793529T ES 08793529 T ES08793529 T ES 08793529T ES 2422739 T3 ES2422739 T3 ES 2422739T3
- Authority
- ES
- Spain
- Prior art keywords
- prevention
- ucb
- gro
- msc
- diagnosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Abstract
Una composición farmacéutica para uso en la prevención de tumores cerebrales, en la que la composiciónfarmacéutica comprende citoblastos mesenquimatosos aislados de sangre del cordón umbilical y/o citoblastosmesenquimatosos propagados a partir de dichos citoblastos mesenquimatosos.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20070087228 | 2007-08-29 | ||
US97296607P | 2007-09-17 | 2007-09-17 | |
KR1020080067247A KR101039235B1 (ko) | 2007-08-29 | 2008-07-10 | 제대혈 유래 간엽줄기세포를 포함하는 인터루킨-8 또는지알오-알파 발현 세포가 관련된 질병의 진단, 예방 또는치료용 조성물 |
US8973308P | 2008-08-18 | 2008-08-18 | |
PCT/KR2008/005026 WO2009028870A2 (en) | 2007-08-29 | 2008-08-27 | Composition for the diagnosis, prevention or treatment of diseases related to cells expressing il-8 or gro-alpha, comprising ucb-mscs |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2422739T3 true ES2422739T3 (es) | 2013-09-13 |
Family
ID=40388015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES08793529T Active ES2422739T3 (es) | 2007-08-29 | 2008-08-27 | Composición para el diagnóstico, prevención o tratamiento de enfermedades relacionadas con células que expresan IL-8 o GRO-, que comprende MSC de UCB |
Country Status (10)
Country | Link |
---|---|
US (2) | US8506948B2 (es) |
EP (1) | EP2180896B1 (es) |
JP (1) | JP5529021B2 (es) |
KR (1) | KR101039235B1 (es) |
CN (2) | CN101815522B (es) |
AU (1) | AU2008293208A1 (es) |
CA (1) | CA2692232C (es) |
ES (1) | ES2422739T3 (es) |
SG (1) | SG184701A1 (es) |
WO (1) | WO2009028870A2 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101039235B1 (ko) | 2007-08-29 | 2011-06-07 | 메디포스트(주) | 제대혈 유래 간엽줄기세포를 포함하는 인터루킨-8 또는지알오-알파 발현 세포가 관련된 질병의 진단, 예방 또는치료용 조성물 |
CA2734236C (en) | 2008-08-20 | 2020-08-25 | Anthrogenesis Corporation | Improved cell composition and methods of making the same |
US8969315B2 (en) | 2010-12-31 | 2015-03-03 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory RNA molecules |
EP2670426B1 (en) | 2011-01-31 | 2017-05-10 | The General Hospital Corporation | Multimodal trail molecules and uses in cellular therapies |
WO2012121577A2 (ko) * | 2011-03-10 | 2012-09-13 | 이화여자대학교 산학협력단 | Pten을 포함하는 줄기세포의 조직 재생능 강화용 조성물 |
ES2707579T3 (es) | 2011-06-01 | 2019-04-04 | Celularity Inc | Tratamiento del dolor usando citoblastos placentarios |
JP2015500810A (ja) * | 2011-11-30 | 2015-01-08 | アドバンスド セル テクノロジー、インコーポレイテッド | 間葉系間質細胞及びその関連用途 |
US20130171115A1 (en) * | 2011-12-30 | 2013-07-04 | Gang Li | Cell-mediated gene therapy for cancer using mesenchymal stem cells expressing a suicide gene |
KR102053385B1 (ko) * | 2012-02-01 | 2019-12-06 | 포항공과대학교 산학협력단 | 12량체 trail 및 hsv-tk 자살유전자를 동시에 발현하는 벡터 및 이를 이용한 항암 줄기세포 치료제 |
CN102731658B (zh) * | 2012-05-15 | 2014-07-30 | 山东大学 | 一种Tat PTD-Endostatin重组蛋白及其制备方法与应用 |
US9862932B2 (en) | 2012-07-24 | 2018-01-09 | The General Hospital Corporation | Oncolytic virus therapy for resistant tumors |
WO2014035474A1 (en) | 2012-08-30 | 2014-03-06 | The General Hospital Corporation | Compositions and methods for treating cancer |
GB201220573D0 (en) * | 2012-11-15 | 2013-01-02 | Univ Central Lancashire | Methods of diagnosing proliferative disorders |
CN103602625B (zh) * | 2013-08-16 | 2015-09-30 | 苏州大学 | 含有重组腺病毒质粒的大肠杆菌及重组腺病毒的应用 |
EP3082834B1 (en) * | 2013-12-11 | 2020-03-11 | The General Hospital Corporation DBA Massachusetts | Stem cell delivered oncolytic herpes simplex virus and methods for treating brain tumors |
JP6519727B2 (ja) * | 2014-09-17 | 2019-05-29 | 国立大学法人山口大学 | 間葉系幹細胞の培養方法、および肝機能障害用治療剤の製造方法 |
ES2861381T3 (es) * | 2015-03-06 | 2021-10-06 | Univ Ajou Ind Academic Coop Found | Agente terapéutico celular para el tratamiento del cáncer y politerapia con el mismo |
CN104726411B (zh) * | 2015-03-27 | 2017-06-23 | 中国人民解放军军事医学科学院基础医学研究所 | 抑制肿瘤生长的重组间充质干细胞及其制备方法与应用 |
WO2016168601A1 (en) * | 2015-04-17 | 2016-10-20 | Khalid Shah | Agents, systems and methods for treating cancer |
KR20190097240A (ko) * | 2016-12-28 | 2019-08-20 | 트랜스진 에스.에이. | 종양용해성 바이러스 및 치료 분자 |
CN108018287A (zh) * | 2018-01-10 | 2018-05-11 | 扬州大学 | 一种抑制山羊卵泡颗粒细胞增殖的特异siRNA及方法 |
CN108553478B (zh) * | 2018-04-02 | 2020-03-20 | 杭州师范大学 | 一种septin基因shRNA在制备septin基因活性抑制剂中的应用 |
US10835558B2 (en) * | 2018-04-16 | 2020-11-17 | Brahm Holdings, Inc. | Mammalian birth tissue composition for tumor treatment |
WO2021024207A1 (en) * | 2019-08-05 | 2021-02-11 | Mesoblast International Sarl | Cellular compositions comprising viral vectors and methods of treatment |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2287447T3 (es) | 2002-02-19 | 2007-12-16 | Medipost, Co., Ltd. | Metodos de aislamiento y expansion del cultivo de celulas troncales/madre mesenquimatosas a partir de sangre del cordon umbilical, y metodo de diferenciacion de celulas troncales/madre mesenquimatosas derivadas de sangre del cordon umbilical en diversos tejidos mesenquimatosos. |
KR20040022134A (ko) * | 2002-09-06 | 2004-03-11 | 송준석 | 인간 간엽줄기 세포와 p53 분비 아데노바이러스를 이용한항암치료방법 |
CA2528669A1 (en) * | 2003-06-09 | 2005-01-20 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
CA2535034A1 (en) | 2003-06-27 | 2005-01-27 | Renomedix Institute Inc | Internallly administered therapeutic agents for diseases in central and peripheral nervous system comprising mesenchymal cells as an active ingredient |
JP2007537272A (ja) * | 2004-05-12 | 2007-12-20 | シェーリング コーポレイション | Cxcr1およびcxcr2ケモカインアンタゴニスト |
KR101322889B1 (ko) * | 2004-08-16 | 2013-10-30 | 셀리서치 코포레이션 피티이 리미티드 | 제대의 양막으로부터 줄기/전구세포의 추출 |
JP2006345726A (ja) * | 2005-06-14 | 2006-12-28 | Hamamatsu Univ School Of Medicine | 脳腫瘍治療用発現ベクター |
WO2007011693A2 (en) | 2005-07-14 | 2007-01-25 | Medistem Laboratories, Inc. | Compositions of placentally-derived stem cells for the treatment of cancer |
KR101022401B1 (ko) * | 2005-09-29 | 2011-03-15 | 아주대학교산학협력단 | 자살유전자를 발현하는 중간엽 줄기세포를 포함하는 암치료용 조성물 |
KR101039235B1 (ko) | 2007-08-29 | 2011-06-07 | 메디포스트(주) | 제대혈 유래 간엽줄기세포를 포함하는 인터루킨-8 또는지알오-알파 발현 세포가 관련된 질병의 진단, 예방 또는치료용 조성물 |
-
2008
- 2008-07-10 KR KR1020080067247A patent/KR101039235B1/ko active IP Right Grant
- 2008-08-27 WO PCT/KR2008/005026 patent/WO2009028870A2/en active Application Filing
- 2008-08-27 AU AU2008293208A patent/AU2008293208A1/en not_active Abandoned
- 2008-08-27 ES ES08793529T patent/ES2422739T3/es active Active
- 2008-08-27 SG SG2012061172A patent/SG184701A1/en unknown
- 2008-08-27 EP EP08793529.2A patent/EP2180896B1/en not_active Not-in-force
- 2008-08-27 CN CN200880104400.XA patent/CN101815522B/zh not_active Expired - Fee Related
- 2008-08-27 CA CA2692232A patent/CA2692232C/en not_active Expired - Fee Related
- 2008-08-27 CN CN2012102455712A patent/CN102776285A/zh active Pending
- 2008-08-27 JP JP2010522804A patent/JP5529021B2/ja not_active Expired - Fee Related
-
2009
- 2009-12-08 US US12/633,622 patent/US8506948B2/en not_active Expired - Fee Related
-
2012
- 2012-11-19 US US13/680,995 patent/US20130189189A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20100143261A1 (en) | 2010-06-10 |
SG184701A1 (en) | 2012-10-30 |
EP2180896B1 (en) | 2013-04-24 |
KR101039235B1 (ko) | 2011-06-07 |
KR20090023070A (ko) | 2009-03-04 |
US8506948B2 (en) | 2013-08-13 |
JP2010537973A (ja) | 2010-12-09 |
AU2008293208A1 (en) | 2009-03-05 |
WO2009028870A2 (en) | 2009-03-05 |
CA2692232A1 (en) | 2009-03-05 |
CA2692232C (en) | 2016-11-22 |
EP2180896A4 (en) | 2011-10-26 |
EP2180896A2 (en) | 2010-05-05 |
JP5529021B2 (ja) | 2014-06-25 |
CN101815522A (zh) | 2010-08-25 |
WO2009028870A3 (en) | 2009-04-23 |
US20130189189A1 (en) | 2013-07-25 |
WO2009028870A4 (en) | 2009-06-04 |
CN102776285A (zh) | 2012-11-14 |
CN101815522B (zh) | 2016-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2422739T3 (es) | Composición para el diagnóstico, prevención o tratamiento de enfermedades relacionadas con células que expresan IL-8 o GRO-, que comprende MSC de UCB | |
AR061171A1 (es) | Proteinas de union al factor de crecimiento de hepatocitos (fch) | |
UY31816A (es) | Agente para el tratamiento y/o prevención de una enfemedad autoinmune y para la formación de células t reguladoras | |
ECSP12012024A (es) | Terapia combinada para el tratamiento del cáncer y ensayos de diagnóstico relacionados | |
WO2009026657A8 (en) | Flavonoid ppar agonists | |
AR078346A1 (es) | Anticuerpos humanos de alta afinidad contra el receptor activado por proteasa de tipo 2 humano | |
AR077333A1 (es) | Anticuerpos humanos de alta afinidad para la angiopoyetina -2 humana | |
UA115122C2 (uk) | Cd3-зв'язувальна молекула, здатна до зв'язування з cd3 людини і cd3, що не є людським | |
BR112013010857A2 (pt) | imonoglubulinas de duplo domínio variável e usos das mesmas | |
BR112014015851A2 (pt) | proteínas de ligação específicas duplas direcionadas contra il-13 e/ou il-17 | |
UY32882A (es) | (heteroarilmetil) tiohidantoínas sustituidas | |
BR112015023797A2 (pt) | proteínas de ligação de especificidade dupla dirigidas contra il-1b e/ou il-17 | |
BR112015012014A2 (pt) | proteínas de ligação específicas duais penetrando a barreira hematoencefálica (bbb) | |
AR061170A1 (es) | Proteinas que se unen con el factor de crecimiento de hepatocitos (hgf) | |
ECSP14001249A (es) | Inmunoenlazadores dirigidos contra el tnf | |
BR112012018132A2 (pt) | "marcadores de células - tronco tumorais e uso dos mesmos". | |
BR112012032008A2 (pt) | anticorpos s100a4 e usos terapêuticos do mesmo | |
DOP2009000269A (es) | Anticuerpos humanizados contra el globulomero ab(20-42) y sus usos | |
PA8772101A1 (es) | Imidazol-triazolopirimidinas sustituidas | |
CL2008002793A1 (es) | Compuestos derivados de amidas sustituidas, inhibidores de la actividad de btk; composicion farmaceutica que los comprende; utiles en el tratamiento del cancer, trastornos oseos, enfermedades autoinmunes, entre otras | |
CY1112320T1 (el) | Τιτλοδοτηση της ταπενταδολης | |
CL2009000402A1 (es) | Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras. | |
EP2175879A4 (en) | TREATMENT OF DISEASES ASSOCIATED WITH PRION PROTEIN | |
PE20150764A1 (es) | Niclosamida para el tratamiento de tumores solidos | |
HN2009003424A (es) | (oxazolidinon-5-il-metil) -2-tiofen-carboxamidas sustituida y su uso en el campo de la coagulacion sanguinea |